Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18102453 [patent_doc_number] => 11542328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => Therapeutic and diagnostic methods relating to cancer stem cells [patent_app_type] => utility [patent_app_number] => 16/435929 [patent_app_country] => US [patent_app_date] => 2019-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 28 [patent_no_of_words] => 31881 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/435929
Therapeutic and diagnostic methods relating to cancer stem cells Jun 9, 2019 Issued
Array ( [id] => 18102453 [patent_doc_number] => 11542328 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-03 [patent_title] => Therapeutic and diagnostic methods relating to cancer stem cells [patent_app_type] => utility [patent_app_number] => 16/435929 [patent_app_country] => US [patent_app_date] => 2019-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 28 [patent_no_of_words] => 31881 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16435929 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/435929
Therapeutic and diagnostic methods relating to cancer stem cells Jun 9, 2019 Issued
Array ( [id] => 16962937 [patent_doc_number] => 20210214436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON [patent_app_type] => utility [patent_app_number] => 17/058335 [patent_app_country] => US [patent_app_date] => 2019-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27207 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -122 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058335 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/058335
MULTI-SPECIFIC BINDING PROTEINS AND IMPROVEMENTS THEREON May 27, 2019 Abandoned
Array ( [id] => 15499053 [patent_doc_number] => 20200049715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-13 [patent_title] => Method of Detecting Cancer [patent_app_type] => utility [patent_app_number] => 16/417042 [patent_app_country] => US [patent_app_date] => 2019-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16417042 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/417042
Method of detecting cancer May 19, 2019 Issued
Array ( [id] => 15711247 [patent_doc_number] => 20200102389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => ANTI-HLA-G ANTIBODIES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/415979 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27363 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415979 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/415979
Anti-HLA-G antibodies and use thereof May 16, 2019 Issued
Array ( [id] => 17022324 [patent_doc_number] => 20210246195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => METHODS OF ISOLATING ALLERGEN-SPECIFIC ANTIBODIES FROM HUMANS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/056384 [patent_app_country] => US [patent_app_date] => 2019-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63770 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -78 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056384 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/056384
Methods of isolating allergen-specific antibodies from humans and uses thereof May 16, 2019 Issued
Array ( [id] => 16778074 [patent_doc_number] => 20210115152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => COMPOSITION OF BISPECIFIC ANTIBODIES AND METHOD OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/055561 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055561 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/055561
COMPOSITION OF BISPECIFIC ANTIBODIES AND METHOD OF USE THEREOF May 14, 2019 Pending
Array ( [id] => 14993749 [patent_doc_number] => 20190315832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS [patent_app_type] => utility [patent_app_number] => 16/413192 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52123 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16413192 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/413192
Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers May 14, 2019 Issued
Array ( [id] => 15008517 [patent_doc_number] => 10450374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-22 [patent_title] => Anti-galectin-9 antibodies and uses thereof [patent_app_type] => utility [patent_app_number] => 16/406713 [patent_app_country] => US [patent_app_date] => 2019-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 64 [patent_no_of_words] => 93743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406713 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/406713
Anti-galectin-9 antibodies and uses thereof May 7, 2019 Issued
Array ( [id] => 19411776 [patent_doc_number] => 12077583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-03 [patent_title] => Antibodies specific to human NECTIN4 [patent_app_type] => utility [patent_app_number] => 17/052960 [patent_app_country] => US [patent_app_date] => 2019-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 27 [patent_no_of_words] => 22136 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 310 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052960 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/052960
Antibodies specific to human NECTIN4 May 5, 2019 Issued
Array ( [id] => 17241962 [patent_doc_number] => 20210361705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => REPROGRAMMING CD4 T CELLS INTO CYTOTOXIC CD8 CELLS BY FORCED EXPRESSION OF CD8aB AND CLASS 1 RESTRICTED T CELL RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/048490 [patent_app_country] => US [patent_app_date] => 2019-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -48 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048490 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048490
Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab and class 1 restricted t cell receptors Apr 17, 2019 Issued
Array ( [id] => 14993823 [patent_doc_number] => 20190315869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => METHODS FOR TREATING CANCER IN PATIENTS WITH ELEVATED LEVELS OF BIM [patent_app_type] => utility [patent_app_number] => 16/384313 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11842 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384313 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/384313
Methods for treating cancer in patients with elevated levels of Bim Apr 14, 2019 Issued
Array ( [id] => 15524839 [patent_doc_number] => 20200054725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => BREAST AND OVARIAN CANCER VACCINES [patent_app_type] => utility [patent_app_number] => 16/370683 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79959 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16370683 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/370683
Breast and ovarian cancer vaccines Mar 28, 2019 Issued
Array ( [id] => 16793007 [patent_doc_number] => 20210122824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => ANTI-PD-L1 ANTIBODIES AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/043454 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043454 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/043454
Anti-PD-L1 antibodies and use thereof Mar 28, 2019 Issued
Array ( [id] => 18202406 [patent_doc_number] => 11584788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms [patent_app_type] => utility [patent_app_number] => 16/365978 [patent_app_country] => US [patent_app_date] => 2019-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 43 [patent_no_of_words] => 58297 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16365978 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/365978
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms Mar 26, 2019 Issued
Array ( [id] => 19955330 [patent_doc_number] => 12325737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-10 [patent_title] => Total afucosylated glycoforms of antibodies produced in cell culture [patent_app_type] => utility [patent_app_number] => 17/040422 [patent_app_country] => US [patent_app_date] => 2019-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 17354 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040422 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040422
Total afucosylated glycoforms of antibodies produced in cell culture Mar 25, 2019 Issued
Array ( [id] => 16583101 [patent_doc_number] => 20210017503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC [patent_app_type] => utility [patent_app_number] => 16/981626 [patent_app_country] => US [patent_app_date] => 2019-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31465 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981626 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/981626
BROAD-SPECTRUM PROTEOME EDITING WITH AN ENGINEERED BACTERIAL UBIQUITIN LIGASE MIMIC Mar 17, 2019 Abandoned
Array ( [id] => 16570705 [patent_doc_number] => 20210009711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => MULTIFUNCTIONAL MOLECULES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/980771 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52634 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -134 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980771 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/980771
MULTIFUNCTIONAL MOLECULES AND USES THEREOF Mar 13, 2019 Abandoned
Array ( [id] => 17149511 [patent_doc_number] => 11142574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-12 [patent_title] => Anti-TIM-3 antibodies [patent_app_type] => utility [patent_app_number] => 16/294474 [patent_app_country] => US [patent_app_date] => 2019-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 17 [patent_no_of_words] => 20103 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16294474 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/294474
Anti-TIM-3 antibodies Mar 5, 2019 Issued
Array ( [id] => 17541040 [patent_doc_number] => 11306151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Anti-TIP-1 antibodies and uses thereof [patent_app_type] => utility [patent_app_number] => 15/733554 [patent_app_country] => US [patent_app_date] => 2019-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 10129 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733554 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/733554
Anti-TIP-1 antibodies and uses thereof Mar 5, 2019 Issued
Menu